Singapore markets open in 7 hours 55 minutes

Atea Pharmaceuticals, Inc. (AVIR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
5.78+0.29 (+5.19%)
As of 01:05PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
No. of analysts3333
Avg. Estimate-0.44-0.54-1.86-2.6
Low estimate-0.49-0.63-2-3.15
High estimate-0.41-0.47-1.76-2.04
Year ago EPS-0.341.341.37-1.86
Revenue estimateCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
No. of analysts3333
Avg. EstimateN/AN/AN/A6M
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/A18M
Year ago salesN/A192.18M351.37MN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history29/09/202130/12/202130/03/202229/06/2022
Est. EPS-0.050.17-0.58-0.52
Actual EPS-0.341.34-0.51-0.38
Difference-0.291.170.070.14
Surprise %-580.00%688.20%12.10%26.90%
EPS trendCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
Current estimate-0.44-0.54-1.86-2.6
7 days ago-0.44-0.54-1.86-2.6
30 days ago-0.44-0.54-1.86-2.58
60 days ago-0.56-0.6-2.2-2.56
90 days ago-0.56-0.6-2.2-2.56
EPS revisionsCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/A1
Growth estimatesAVIRIndustrySector(s)S&P 500
Current qtr.-29.40%N/AN/AN/A
Next qtr.-140.30%N/AN/AN/A
Current year-235.80%N/AN/AN/A
Next year-39.80%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A